Work

Targeting Ras in Myeloid Leukemias

Year: 2008
Type: review
Abstract: Ras proteins normally relay growth-promoting signals from many activated cell surface receptors, and they are altered by oncogenic point mutations in approximately 30% of human cancers. Activating KRAS and NRAS mutations are especially common in malignancies of the pancreas, lung, and colon, and in myeloid leukemia. Here, we discuss general strategies for targeting hyperactive Ras signaling in cancer cells with specific reference to myeloid malignancies.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2129792506
FWCI: 0.78
Cites: 57
Cited by: 88
Related to: 9